Back to School: How biopharma can reboot drug development. Access exclusive analysis here

105AD7: Began Phase I/II testing

Onyvax Ltd., London, U.K.
Product: 105AD7
Business: Cancer
Therapeutic

Read the full 93 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE